WilmerHale Wants To Skip Ch. 11 Client Disclosures
Software-based medicine venture Pear Therapeutics asked a Delaware bankruptcy judge Thursday for permission to retain WilmerHale in its Chapter 11 case despite the firm's claims that it can't reveal the names...To view the full article, register now.
Already a subscriber? Click here to view full article